Log in to save to my catalogue

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6563914

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

About this item

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Treatment of latent tuberculosis infection is an important control measure, especially in patients coinfected with HIV. In this international phase 3 trial, 1 month of isoniazid plus rifapentine was noninferior to the standard 9 months of isoniazid in HIV-infected patients.

Alternative Titles

Full title

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6563914

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6563914

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1806808

How to access this item